This book observes the idea of race as a false representation for the cause of disease. Race-based medicine, an emerging field in pharmacology, aims to create a specialty market based on racial groups. Within this market, the drug BiDil set a precedent in this area of medicine targeting African Americans as its first racial group. Consequently, selecting African Americans as a “starter group” led to ethical questions regarding the motive behind race-based medicine within the context of the larger treatment of blacks in American medical history. This book therefore links medicine and American eugenics, examines race-based medicine’s influence on the perception of the black body, traces the influence of BiDil’s approval on the resurgence of race-based medicine, and assesses the black church’s response to race-based medicine using black liberation theology as a means to social justice.
Lieferbar
ISBN | 9789811329913 |
---|---|
Sprache | eng |
Cover | B, Medical Anthropology, Theory of Medicine/Bioethics, History of Medicine, Pharmacology/Toxicology, Health Sciences, Pharmacology, Social Sciences, Medical Ethics, Medicine—History, Human biology, Bioethics, Medicine: general issues, Fester Einband |
Verlag | Springer Nature EN |
Jahr | 2018 |
Dieser Artikel hat noch keine Bewertungen.